Nov 04, 2019 - Let us take a look at five drug/biotech companies, which are supposed to release their quarterly results on Nov 5.
Nov 08, 2019 - Novo Nordisk (NVO) and Allergan (AGN) release Q3 results. FDA approves Sanofi's quadrivalent flu vaccine for older adults and Novartis' long-acting biosimilar version of Amgen's Neulasta.
Nov 08, 2019 - Teva Pharmaceutical (TEVA) misses earnings estimate but beats the same for sales. The company increases the lower end of its 2019 sales and earnings guidance. Shares rise.
Nov 12, 2019 - Top Stock Reports for Booking Holdings, Allergan & Honda Motor Co.
Nov 19, 2019 - Aerie (AERI) will acquire Spanish ophthalmic pharmaceutical company, Avizorex Pharma, to add a mid-stage dry eye disease candidate to its pipeline.
Nov 20, 2019 - Alkermes (ALKS) submits NDA to the FDA seeking approval of ALKS 3831 for the treatment of schizophrenia and bipolar I disorder.
Dec 10, 2019 - Following the new deals in the healthcare space, a few biotech ETFs hit new highs.
Jan 03, 2020 - Geopolitcal headwinds sent stocks lower on Friday as US officials confirmed that President Trump's airstrike killed Iran's top military commander.
Jan 03, 2020 - European authorities accept Aerie's (AERI) filing for its second ophthalmology drug, Roclanda.
Jan 06, 2020 - Editas (EDIT) progresses well on developing its lead candidate EDIT-101 to treat LCA10, a rare genetic illness that causes blindness. Excessive reliance on partners for revenues remains a concern.